BioSmart Co.Ltd Capital Reinvestment Ratio
BioSmart Co.Ltd capital reinvestment ratio. BioSmart Co.Ltd (038460) has a Capital Reinvestment Ratio of 0.16x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩7.59 Billion) in capital expenditures (₩1.22 Billion). Check BioSmart Co.Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of BioSmart Co.Ltd (2010–2024)
Capital reinvestment ratio of BioSmart Co.Ltd from 2010 to 2024. This chart tracks BioSmart Co.Ltd's Capital Reinvestment Ratio across 9 annual periods. Also explore BioSmart Co.Ltd (038460) net asset momentum to track the company's year-over-year net asset growth rate.
BioSmart Co.Ltd Capital Reinvestment Ratio by Year (2010–2024)
BioSmart Co.Ltd capital reinvestment ratio by year from 2010 to 2024. For the full cash flow conversion analysis, see BioSmart Co.Ltd (038460) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.28x | ₩3.80 Billion | ₩8.66 Billion | ▼ -45.9% |
| 2023 | 4.22x | ₩1.17 Billion | ₩4.92 Billion | ▲ +301.7% |
| 2022 | 1.05x | ₩5.59 Billion | ₩5.87 Billion | ▼ -75.8% |
| 2021 | 4.34x | ₩1.20 Billion | ₩5.22 Billion | ▲ +656.0% |
| 2018 | 0.57x | ₩5.81 Billion | ₩3.34 Billion | ▼ -19.1% |
| 2014 | 0.71x | ₩1.31 Billion | ₩927.27 Million | ▲ +265.3% |
| 2013 | 0.19x | ₩3.85 Billion | ₩748.17 Million | ▲ +87.0% |
| 2012 | 0.10x | ₩8.62 Billion | ₩895.45 Million | ▼ -16.0% |
| 2010 | 0.12x | ₩4.76 Billion | ₩589.05 Million | — |